{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:43:45Z","timestamp":1792457025094,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T00:00:00Z","timestamp":1367539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10753-013-9643-x","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T08:53:24Z","timestamp":1367484804000},"page":"1101-1106","source":"Crossref","is-referenced-by-count":20,"title":["BML-11, A Lipoxin Receptor Agonist, Protected Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats"],"prefix":"10.1007","volume":"36","author":[{"given":"Xiao-Yan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,3]]},"reference":[{"key":"9643_CR1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0090-6980(02)00047-3","volume":"68\u201369","author":"CN Serhan","year":"2002","unstructured":"Serhan, C.N. 2002. Lipoxin and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins & Other Lipid Mediators 68\u201369: 433\u2013455.","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"9643_CR2","doi-asserted-by":"crossref","first-page":"15736","DOI":"10.1073\/pnas.0404722101","volume":"101","author":"S Fiorucci","year":"2004","unstructured":"Fiorucci, S., J.L. Wallace, A. Mencarelli, et al. 2004. A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proceedings of the National Academy of Sciences of the United States of America 101: 15736\u201315741.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9643_CR3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0165-6147(00)01771-5","volume":"22","author":"B McMahon","year":"2001","unstructured":"McMahon, B., S. Mitchell, H.R. Brady, et al. 2001. Lipoxins: revelations on resolution. Trends in Pharmacological Sciences 22: 391\u2013395.","journal-title":"Trends in Pharmacological Sciences"},{"key":"9643_CR4","first-page":"S56","volume":"58","author":"YM O'Meara","year":"1997","unstructured":"O'Meara, Y.M., and H.R. Brady. 1997. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. Kidney International. Supplement 58: S56\u2013S61.","journal-title":"Kidney International. Supplement"},{"issue":"3","key":"9643_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1515\/CCLM.1999.051","volume":"37","author":"P Diamond","year":"1999","unstructured":"Diamond, P., A. McGinty, D. Sugrue, et al. 1999. Regulation of leukocyte trafficking by lipoxins. Clinical Chemistry and Laboratory Medicine 37(3): 293\u2013297.","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"9643_CR6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nm1355","volume":"12","author":"FS Machado","year":"2006","unstructured":"Machado, F.S., J.E. Johndrow, L. Esper, et al. 2006. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nature Medicine 12: 330\u2013334.","journal-title":"Nature Medicine"},{"key":"9643_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.plefa.2005.05.003","volume":"73","author":"N Chiang","year":"2005","unstructured":"Chiang, N., M. Arita, and C.N. Serhan. 2005. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins, Leukotrienes, and Essential Fatty Acids 73: 163\u2013177.","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"9643_CR8","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/01.ASN.0000032417.73640.72","volume":"13","author":"S Mitchell","year":"2002","unstructured":"Mitchell, S., G. Thomas, K. Harvey, et al. 2002. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. Journal of the American Society of Nephrology 13: 2497\u20132507.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"44","key":"9643_CR9","doi-asserted-by":"crossref","first-page":"14609","DOI":"10.1021\/bi00044a041","volume":"34","author":"CN Serhan","year":"1995","unstructured":"Serhan, C.N., J.F. Maddox, N.A. Petasis, et al. 1995. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34(44): 14609\u201314615.","journal-title":"Biochemistry"},{"issue":"3","key":"9643_CR10","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/S0006-291X(05)81354-3","volume":"180","author":"TH Lee","year":"1991","unstructured":"Lee, T.H., P. Lympany, and A.E. Crea. 1991. Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure\u2013function relationships. Biochemical and Biophysical Research Communications 180(3): 1416\u20131421.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"11","key":"9643_CR11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1872-034X.2007.00154.x","volume":"37","author":"L Zhang","year":"2007","unstructured":"Zhang, L., J. Wan, H. Li, et al. 2007. Protective effects of BML-111, a lipoxin A(4) receptor agonist, on carbon tetrachloride-induced liver injury in mice. Hepatology Research 37(11): 948\u2013956.","journal-title":"Hepatology Research"},{"issue":"7","key":"9643_CR12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.resuscitation.2011.12.035","volume":"83","author":"J Gong","year":"2012","unstructured":"Gong, J., S. Guo, H.B. Li, et al. 2012. BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats. Resuscitation 83(7): 907\u2013912.","journal-title":"Resuscitation"},{"key":"9643_CR13","doi-asserted-by":"crossref","unstructured":"Wang Q, Li R, Ying BY, et al. 2013 Mar 7. Lipoxin A4 activates alveolar epithelial ENaC, Na, K-ATPase and increases alveolar fluid clearance. American Journal of Respiratory Cell and Molecular Biology.","DOI":"10.1165\/rcmb.2012-0274OC"},{"issue":"4","key":"9643_CR14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.reprotox.2012.09.009","volume":"34","author":"F Lin","year":"2012","unstructured":"Lin, F., P. Zeng, Z. Xu, et al. 2012. Treatment of Lipoxin A(4) and its analogue on low-dose endotoxin induced preeclampsia in rat and possible mechanisms. Reproductive Toxicology 34(4): 677\u2013685.","journal-title":"Reproductive Toxicology"},{"issue":"6","key":"9643_CR15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/bja\/aer299","volume":"107","author":"L Pei","year":"2011","unstructured":"Pei, L., J. Zhang, F. Zhao, et al. 2011. Annexin 1 exerts anti-nociceptive effects after peripheral inflammatory pain through formyl-peptide-receptor-like 1 in rat dorsal root ganglion. British Journal of Anaesthesia 107(6): 948\u2013958.","journal-title":"British Journal of Anaesthesia"},{"issue":"4","key":"9643_CR16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1476-5381.2010.00950.x","volume":"161","author":"FP Conte","year":"2010","unstructured":"Conte, F.P., O. Menezes-de-Lima Jr., W.A. Verri Jr., et al. 2010. Lipoxin A(4) attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects. British Journal of Pharmacology 161(4): 911\u2013924.","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"9643_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00011-007-7141-z","volume":"57","author":"L Zhang","year":"2008","unstructured":"Zhang, L., X. Zhang, P. Wu, et al. 2008. BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis. Inflammation Research 57(4): 157\u2013162.","journal-title":"Inflammation Research"},{"key":"9643_CR18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1872-034X.2009.00520.x","volume":"39","author":"XY Zhou","year":"2009","unstructured":"Zhou, X.Y., Y.S. Li, P. Wu, et al. 2009. Lipoxin A4 inhibited hepatocyte growth factor-induced invasion of human hepatoma cells. Hepatology Research 39: 921\u2013930.","journal-title":"Hepatology Research"},{"key":"9643_CR19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2011.05.020","volume":"309","author":"H Hao","year":"2011","unstructured":"Hao, H., M. Liu, P. Wu, et al. 2011. Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment. Cancer Letters 309: 85\u201394.","journal-title":"Cancer Letters"},{"key":"9643_CR20","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1158\/1535-7163.MCT-10-0173","volume":"9","author":"Y Chen","year":"2010","unstructured":"Chen, Y., H. Hao, S. He, et al. 2010. Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Molecular Cancer Therapeutics 9: 2164\u20132174.","journal-title":"Molecular Cancer Therapeutics"},{"key":"9643_CR21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","volume":"117","author":"JP Iredale","year":"2007","unstructured":"Iredale, J.P. 2007. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. The Journal of Clinical Investigation 117: 539\u2013548.","journal-title":"The Journal of Clinical Investigation"},{"key":"9643_CR22","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1172\/JCI44957","volume":"121","author":"T Kodama","year":"2011","unstructured":"Kodama, T., T. Takehara, H. Hikita, et al. 2011. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. The Journal of Clinical Investigation 121: 3343\u20133356.","journal-title":"The Journal of Clinical Investigation"},{"key":"9643_CR23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner, A.M., and R. Weiskirchen. 2006. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. Journal of Cellular and Molecular Medicine 10: 76\u201399.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9643_CR24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea, V., and S.L. Friedman. 2011. Pathogenesis of liver fibrosis. Annual Review of Pathology 6: 425\u2013456.","journal-title":"Annual Review of Pathology"},{"key":"9643_CR25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","volume":"254","author":"SL Friedman","year":"2008","unstructured":"Friedman, S.L. 2008. Hepatic fibrosis\u2014overview. Toxicology 254: 120\u2013129.","journal-title":"Toxicology"},{"key":"9643_CR26","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/00004836-200211002-00003","volume":"35","author":"NN Nissen","year":"2002","unstructured":"Nissen, N.N., and P. Martin. 2002. Hepatocellular carcinoma: the high-risk patient. Journal of Clinical Gastroenterology 35: S79\u2013S85.","journal-title":"Journal of Clinical Gastroenterology"},{"key":"9643_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R., and D.A. Brenner. 2005. Liver fibrosis. The Journal of Clinical Investigation 115: 209\u2013218.","journal-title":"The Journal of Clinical Investigation"},{"key":"9643_CR28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","volume":"7","author":"SL Friedman","year":"2010","unstructured":"Friedman, S.L. 2010. Evolving challenges in hepatic fibrosis. Nature Reviews. Gastroenterology & Hepatology 7: 425\u2013436.","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"9643_CR29","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman, S.L. 2008. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655\u20131669.","journal-title":"Gastroenterology"},{"key":"9643_CR30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","volume":"18","author":"A Leask","year":"2004","unstructured":"Leask, A., and D.J. Abraham. 2004. TGF-beta signaling and the fibrotic response. The FASEB Journal 18: 816\u2013827.","journal-title":"The FASEB Journal"},{"key":"9643_CR31","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1096\/fj.11-185017","volume":"25","author":"E B\u00f6rgeson","year":"2011","unstructured":"B\u00f6rgeson, E., N.G. Docherty, M. Murphy, et al. 2011. Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis. The FASEB Journal 25: 2967\u20132979.","journal-title":"The FASEB Journal"},{"issue":"2","key":"9643_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2613.2006.00507.x","volume":"88","author":"T Lawrence","year":"2007","unstructured":"Lawrence, T., and D.W. Gilroy. 2007. Chronic inflammation: a failure of resolution? International Journal of Experimental Pathology 88(2): 85\u201394.","journal-title":"International Journal of Experimental Pathology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-013-9643-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-013-9643-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-013-9643-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:38:14Z","timestamp":1559245094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-013-9643-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,3]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9643"],"URL":"https:\/\/doi.org\/10.1007\/s10753-013-9643-x","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,3]]}}}